Stryker Corporation (NYSE:SYK) insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction on Friday, August 4th. The stock was sold at an average price of $146.36, for a total value of $731,800.00. Following the transaction, the insider now directly owns 88,207 shares in the company, valued at $12,909,976.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Stryker Corporation (NYSE SYK) traded down 0.74% during midday trading on Friday, reaching $144.29. 1,673,285 shares of the company’s stock traded hands. Stryker Corporation has a 1-year low of $106.48 and a 1-year high of $148.84. The company has a market capitalization of $53.97 billion, a PE ratio of 32.21 and a beta of 0.80. The firm’s 50 day moving average price is $144.61 and its 200-day moving average price is $136.38.

Stryker Corporation (NYSE:SYK) last issued its earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.51 by $0.02. The business had revenue of $3.01 billion for the quarter, compared to the consensus estimate of $2.98 billion. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The business’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.39 earnings per share. Equities analysts expect that Stryker Corporation will post $6.50 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Stockholders of record on Friday, September 29th will be issued a $0.425 dividend. This represents a $1.70 annualized dividend and a dividend yield of 1.18%. The ex-dividend date of this dividend is Thursday, September 28th. Stryker Corporation’s payout ratio is 37.95%.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/08/19/lonny-j-carpenter-sells-5000-shares-of-stryker-corporation-syk-stock-updated.html.

A number of equities analysts have recently issued reports on the company. Cowen and Company reaffirmed a “buy” rating and set a $160.00 price target (up from $150.00) on shares of Stryker Corporation in a research report on Sunday, July 30th. BidaskClub raised Stryker Corporation from a “hold” rating to a “buy” rating in a research report on Thursday. Zacks Investment Research downgraded Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Thursday. Royal Bank Of Canada upped their target price on Stryker Corporation from $140.00 to $155.00 and gave the company an “outperform” rating in a research report on Friday, July 28th. Finally, Oppenheimer Holdings, Inc. set a $148.00 target price on Stryker Corporation and gave the company a “hold” rating in a research report on Friday, July 28th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and twelve have given a buy rating to the company. Stryker Corporation presently has a consensus rating of “Hold” and a consensus target price of $144.03.

Several hedge funds have recently modified their holdings of SYK. WFG Advisors LP increased its stake in shares of Stryker Corporation by 1.6% in the second quarter. WFG Advisors LP now owns 2,041 shares of the medical technology company’s stock valued at $283,000 after buying an additional 32 shares during the last quarter. Toronto Dominion Bank increased its stake in shares of Stryker Corporation by 25.8% in the second quarter. Toronto Dominion Bank now owns 105,403 shares of the medical technology company’s stock valued at $14,625,000 after buying an additional 21,585 shares during the last quarter. Cetera Investment Advisers increased its stake in shares of Stryker Corporation by 38.2% in the second quarter. Cetera Investment Advisers now owns 4,468 shares of the medical technology company’s stock valued at $617,000 after buying an additional 1,235 shares during the last quarter. EP Wealth Advisors LLC increased its stake in shares of Stryker Corporation by 2.0% in the second quarter. EP Wealth Advisors LLC now owns 93,475 shares of the medical technology company’s stock valued at $12,972,000 after buying an additional 1,868 shares during the last quarter. Finally, Advisory Services Network LLC increased its stake in shares of Stryker Corporation by 1.8% in the second quarter. Advisory Services Network LLC now owns 3,398 shares of the medical technology company’s stock valued at $472,000 after buying an additional 59 shares during the last quarter. 73.79% of the stock is currently owned by institutional investors and hedge funds.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Insider Buying and Selling by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.